Products
| Product | Strength | Pack Size |
|---|---|---|
| Amikacin Solution for Injection (Amiwok) | 500mg/2ml | 1 vial / box |
| Cefepime for Injection USP | 1000mg | 1 vial / box |
| Ciprofloxacin Solution for Infusion | 200mg/100ml | 10 bags / box |
| Clindamycin Capsules | 150mg | 100 capsules / box |
| Daptomycin Powder for Solution for Injection or Infusion | 500mg | 1 vial / box |
| Imipenem/Cilastatin Powder for Solution for Infusion (Prepenem) | 500mg/500mg | 10 vials / box |
| Levofloxacin Solution for Infusion | 500mg/100ml | 1 vial / box |
| Levofloxacin Tablets | 250mg | 10 tablets / box 50 tablets / bottle 100 tablets / box |
| Linezolid Tablets (Lizedia) | 600mg | 10 tablets / box |
| Meropenem Powder for Solution for Injection or Infusion | 500mg | 10 vials / box |
| Meropenem Powder for Solution for Injection or Infusion | 1g | 10 vials / box |
| Moxifloxacin Tablets (Rivomoxi) | 400mg | 10 tablets / box |
* The above product list shows our products which are approved by Hong Kong Department of Health only. It does not mean that all products are already placed in the market. For any product or business enquiries please contact us at ichk@ichk.org or (852) 2891 0581 for further details.
Bacterial Infections
Although a majority of bacteria are harmless, some may cause bacterial infections. Bacterial infections can be treated with antibiotics. However, antimicrobial spectrum among different antibiotics varies. Before the responsible pathogen is identified, broad-spectrum antibiotics are often prescribed as an empirical therapy for severe infections.
Carbapenems
Carbapenems (e.g. Imipenem/Cilastatin, Meropenem) are effective against Gram-positive, Gram-negative and anaerobic bacteria. They are the treatment of choice against ESBL-producing bacteria, which are resistant to most penicillins and cephalosporins. For MRSA infections, other antibiotics should be considered due to carbapenem resistance. Imipenem/Cilastatin is not recommended in bacterial meningitis due to potential risk of seizures.
Fluoroquinolones
Fluoroquinolones (e.g. Ciprofloxacin, Levofloxacin, Moxifloxacin) are effective against Gram-positive and Gram-negative bacteria. They are commonly used in patients with penicillin allergy. However, they are associated with an increased risk of tendonitis and tendon rupture. They are also contraindicated in pregnancy. Moxifloxacin is a fourth-generation fluoroquinolone. It is more potent and less likely to develop bacterial resistance than other fluoroquinolones.
Aminoglycosides
Aminoglycosides (e.g. Gentamicin, Amikacin) are effective against Gram-negative bacteria. They are the treatment of choice against against Pseudomonas aeruginosa, which are resistant to a variety of antibiotics. However, they are potentially nephrotoxic and ototoxic and patients must be carefully monitored. Amikacin is effective against bacteria that are resistant to gentamicin and other aminoglycosides.
Carbapenems
Carbapenems (e.g. Imipenem/Cilastatin, Meropenem) are effective against Gram-positive, Gram-negative and anaerobic bacteria. They are the treatment of choice against ESBL-producing bacteria, which are resistant to most penicillins and cephalosporins. For MRSA infections, other antibiotics should be considered due to carbapenem resistance. Imipenem/Cilastatin is not recommended in bacterial meningitis due to potential risk of seizures.
Fluoroquinolones
Fluoroquinolones (e.g. Ciprofloxacin, Levofloxacin, Moxifloxacin) are effective against Gram-positive and Gram-negative bacteria. They are commonly used in patients with penicillin allergy. However, they are associated with an increased risk of tendonitis and tendon rupture. They are also contraindicated in pregnancy. Moxifloxacin is a fourth-generation fluoroquinolone. It is more potent and less likely to develop bacterial resistance than other fluoroquinolones.
Aminoglycosides
Aminoglycosides (e.g. Gentamicin, Amikacin) are effective against Gram-negative bacteria. They are the treatment of choice against against Pseudomonas aeruginosa, which are resistant to a variety of antibiotics. However, they are potentially nephrotoxic and ototoxic and patients must be carefully monitored. Amikacin is effective against bacteria that are resistant to gentamicin and other aminoglycosides.